Clinical Trials Logo

Clinical Trial Summary

Pneumoconiosis is relatively prevalent in low/middle-income countries, and it remains a challenging task to accurately and reliably diagnose pneumoconiosis. The investigators implemented a deep learning solution and clarified the potential of deep learning in pneumoconiosis diagnosis by comparing its performance with two certified radiologists. The deep learning demonstrated a unique potential in classifying pneumoconiosis.


Clinical Trial Description

The investigators retrospectively collected a dataset consisting of 1881 chest X-ray images in the form of digital radiography. These images were acquired in a screening setting on subjects who had a history of working in an environment that exposed them to harmful dust. Among these subjects, 923 were diagnosed with pneumoconiosis, and 958 were normal. To identify the subjects with pneumoconiosis, the investigators applied a classical deep convolutional neural network (CNN) called Inception-V3 to these image sets and validated the classification performance of the trained models using the area under the receiver operating characteristic curve (AUC). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04963348
Study type Observational
Source Peking University Third Hospital
Contact
Status Completed
Phase
Start date January 1, 2015
Completion date December 31, 2019

See also
  Status Clinical Trial Phase
Completed NCT04022902 - The Experience of Patients and Family Caregivers in Managing Pneumoconiosis in the Family Context
Recruiting NCT05365802 - FAPI PET for Lung Fibrosis Early Phase 1
Completed NCT00005280 - Specialized Center of Research in Occupational and Immunologic Lung Disease N/A
Completed NCT02668068 - A Study on Pneumoconiosis Treated With Whole-lung Lavage Combined With Mesenchymal Stem Cells Phase 1
Recruiting NCT04952675 - Evaluation of Pneumoconiosis High Risk Early Warning Models
Not yet recruiting NCT05288179 - Efficacy and Safety of Pirfenidone Capsules in the Treatment of Pneumoconiosis Phase 3